5000872026-03-025000872026-03-022026-03-02xbrli:pure

CIPLA LIMITED

CIPLA

New

Incorporation

2026-03-02

We hereby notify that Cipla (EU) Limited, UK, a wholly owned subsidiary of the Company has incorporated a new wholly owned subsidiary named ‘Cipla Middle East Company’ in the Kingdom of Saudi Arabia, effective 1st March, 2026. The confirmation of incorporation was received on 2nd March, 2026 by the Company.

2026-03-02

Cipla (EU) Limited

Material Subsidiary

Cipla Middle East Company

Pharmaceutical industry

Cipla Middle East Company has been incorporated as wholly owned subsidiary (“WOS”) in the Kingdom of Saudi Arabia (“KSA”) by Cipla (EU) Limited, UK, WOS of the Company w.e.f. 1st March, 2026 with the objective of establishing a legal entity for manufacturing and distribution of pharmaceutical products and hold marketing authorisations in KSA.

Cost/Price

2026-03-01

Kingdom of Saudi Arabia